Carsten T Wotjak Selected Research

Carsten T Wotjak Research Topics

Disease

12	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2016 - 01/2007
7	Schizophrenia (Dementia Praecox) 10/2022 - 01/2013
5	Cognitive Dysfunction 10/2022 - 01/2019
5	Anxiety Disorders (Anxiety Disorder) 01/2021 - 07/2005
5	Pain (Aches) 01/2018 - 01/2007
5	Mental Disorders (Mental Disorder) 01/2018 - 01/2007
5	Wounds and Injuries (Trauma) 05/2016 - 02/2009
3	Pancreatitis 01/2018 - 10/2014
2	Major Depressive Disorder (Major Depressive Disorders) 01/2018 - 01/2008
2	Hyperalgesia 01/2018 - 10/2014
2	Visceral Pain 01/2018 - 10/2014
2	Seizures (Absence Seizure) 07/2011 - 08/2006
1	Pathologic Processes 01/2022
1	Chronic Pain 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Prodromal Symptoms 01/2021
1	Neurobehavioral Manifestations 01/2020
1	Obesity 01/2019
1	Catalepsy 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015
1	Abdominal Pain (Pain, Abdominal) 10/2014
1	Bradycardia 12/2013
1	Mood Disorders (Mood Disorder) 04/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2012
1	Shock 02/2012
1	Panic Disorder (Panic Attack) 01/2012
1	Temporal Lobe Epilepsy 07/2011
1	Anhedonia 01/2011
1	Fasciculation (Fasciculations) 02/2004

Drug/Important Bio-Agent (IBA)

10	EndocannabinoidsIBA 10/2022 - 08/2006
4	Fluoxetine (Prozac)FDA LinkGeneric 05/2016 - 01/2012
3	Methylazoxymethanol AcetateIBA 10/2022 - 01/2019
3	CannabidiolIBA 01/2021 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2018
3	CannabinoidsIBA 01/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2015 - 02/2009
2	Antimitotic AgentsIBA 10/2022 - 01/2019
2	AM 251 (AM251)IBA 10/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 07/2011
2	RimonabantIBA 01/2019 - 01/2018
2	CeruletideIBA 01/2018 - 12/2015
2	Biological ProductsIBA 12/2017 - 11/2007
2	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2017 - 12/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 01/2008
1	EnzymesIBA 01/2022
1	LipidsIBA 01/2022
1	Dronabinol (THC)FDA LinkGeneric 12/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	General AnestheticsIBA 01/2021
1	Inositol (Myoinositol)IBA 01/2021
1	Isoflurane FDA LinkGeneric 01/2021
1	Dopamine D3 ReceptorsIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	GlucocorticoidsIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	6-methyladenineIBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2016
1	Designer DrugsIBA 12/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2015
1	mesoglycanIBA 01/2015
1	Glycogen Synthase (Synthase I)IBA 01/2015
1	resiniferatoxinIBA 10/2014
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2014
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 10/2014
1	TRPV Cation ChannelsIBA 10/2014
1	1,2- dihexadecyl- sn- glycero- 3- phosphocholineIBA 01/2014
1	Therapeutic UsesIBA 04/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	LipoxinsIBA 12/2012
1	AMPA Receptors (AMPA Receptor)IBA 02/2012
1	DMP 696IBA 02/2012
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2012
1	HydrolasesIBA 07/2011
1	anandamide (arachidonylethanolamide)IBA 07/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2011
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 07/2011
1	ManganeseIBA 05/2011
1	SolutionsIBA 01/2011
1	N-acetylaspartate (N-acetyl aspartate)IBA 02/2009
1	TRPV1 receptorIBA 01/2007
1	Kainic Acid (Kainate)IBA 08/2006
1	Immunoglobulins (Immunoglobulin)IBA 02/2004
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 02/2004

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2007
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2005
1	Secondary Prevention 02/2009